Reportstack is one of the largest online libraries of market research publications. We are the fastest growing and most preferred provider of business intelligence in the market today. We partner with the world's top publishers and research houses to bring to you expert analysis, accurate data and market information along with the best customer support and user experience. For more details, please visit www.reportstack.com
Thursday, 13 April 2017
Research Insights on Global Flavomycin Market 2017-2022
Global Flavomycin Market Outlook 2017-2022 is a new market research publication announced by Reportstack. Bambermycins (Flavomycin) is a complex of antibiotics obtained from Streptomyces bambergiensis used as a food additive for poultry and swine. The complex consists mainly of moenomycins A and C. Flavomycin is a performance enhancing antibiotic intended and available solely for use in animal nutrition. Its mechanism of action is to inhibit the synthesis of the bacterial wall. Flavomycin is predominately effective against gram-positive pathogenic bacteria.
This report provides detailed analysis of worldwide markets for Flavomycin from 2011-2016, and provides extensive market forecasts (2016-2021) by region/country and subsectors. It covers the volumes, prices, historical growth and future perspectives in the Flavomycin market and further lays out an analysis of the factors influencing the supply/demand for Flavomycin, and the opportunities/challenges faced by industry participants. It also acts as an essential tool to companies active across the value chain and to the new entrants by enabling them to capitalize the opportunities and develop business strategies.
The report has been prepared based on the synthesis, analysis, and interpretation of information about the global Flavomycin market collected from specialized sources. The report covers key technological developments in the recent times and profiles leading players in the market and analyzes their key strategies. The competitive landscape section of the report provides a clear insight into the market share analysis of key industry players. The major players in the global Flavomycin market are Merck (USA), Eli Lilly (USA), Biovet (Bulgaria), EWHA (Korea), China Animal Husbandry Group (China), Sunny Nutrition Technology (China), Shandong Shengli (China), Zhejiang Shenghua Baike (China), etc.
The report provides separate comprehensive analytics for the North America, Europe, Asia-Pacific, Middle East and Africa and Rest of World. In this sector, global competitive landscape and supply/demand pattern of Flavomycin industry has been provided.
Merck (USA), Eli Lilly (USA), Biovet (Bulgaria), EWHA (Korea), China Animal Husbandry Group (China), Sunny Nutrition Technology (China), Shandong Shengli (China), Zhejiang Shenghua Baike (China)